For: | Hsiao CY, Pilmore HL, Zhou L, de Zoysa JR. Outcomes of renal transplant recipients with BK virus infection and BK virus surveillance in the Auckland region from 2006 to 2012. World J Nephrol 2016; 5(6): 497-506 [PMID: 27872831 DOI: 10.5527/wjn.v5.i6.497] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v5/i6/497.htm |
Number | Citing Articles |
1 |
Daniel B. Rasmussen, Dina L. Møller, Sebastian R. Hamm, Álvaro H. Borges, Alex C. Y. Nielsen, Nikolai S. Kirkby, Søren S. Sørensen, Susanne D. Nielsen. BKPyV DNAemia in Kidney Transplant Recipients Undergoing Regular Screening: A Single-Centre Cohort Study. Microorganisms 2023; 12(1): 65 doi: 10.3390/microorganisms12010065
|
2 |
S. S. Nikitin, N. B. Guseva, S. A. Kononova. Cystitis of viral etiology in children from the point of view of a urologist. Meditsinskiy sovet = Medical Council 2024; (19): 146 doi: 10.21518/ms2024-377
|
3 |
Amber L. Hertz‐Tang, Brad C. Astor, Didier A. Mandelbrot, Maha A. Mohamed, Arjang Djamali, Sandesh Parajuli. BK viremia is not associated with adverse outcomes in the absence of BK nephropathy. Clinical Transplantation 2018; 32(7) doi: 10.1111/ctr.13283
|
4 |
Stephanie Chong, Michelle Antoni, Andrew Macdonald, Matthew Reeves, Mark Harber, Ciara N. Magee. BK virus: Current understanding of pathogenicity and clinical disease in transplantation. Reviews in Medical Virology 2019; 29(4) doi: 10.1002/rmv.2044
|
5 |
Yasuhito Funahashi. BK Virus-Associated Nephropathy after Renal Transplantation. Pathogens 2021; 10(2): 150 doi: 10.3390/pathogens10020150
|
6 |
Roee Dvir, Vera Paloschi, Filippo Canducci, Giacomo Dell’Antonio, Sara Racca, Rossana Caldara, Giuseppe Pantaleo, Massimo Clementi, Antonio Secchi. IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06915-4
|
7 |
Rafael B. Varella, Ana Carolina J. Zalona, Nuria C. Diaz, Mariano G. Zalis, Guilherme Santoro-Lopes. BK polyomavirus genotypes Ia and Ib1 exhibit different biological properties in renal transplant recipients. Virus Research 2018; 243: 65 doi: 10.1016/j.virusres.2017.10.018
|
8 |
Stéphanie Gomes Santos de Almeida, Guilherme Santoro-Lopes, Flavia Savassi-Ribas, Tereza Cristina Simão Wagner, Tereza Azevedo Matuck, Deise de Boni Monteiro de Carvalho, Ana Carolina Jonard Zalona, Mariano Gustavo Zalis, Rafael Brandão Varella. Screening for BKV-DNAEMIA after renal transplantation in a resource limited setting. Diagnostic Microbiology and Infectious Disease 2020; 96(4): 114979 doi: 10.1016/j.diagmicrobio.2019.114979
|
9 |
Baptiste Demey, Claire Tinez, Catherine François, François Helle, Gabriel Choukroun, Gilles Duverlie, Sandrine Castelain, Etienne Brochot. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review. Journal of Clinical Virology 2018; 109: 6 doi: 10.1016/j.jcv.2018.10.002
|
10 |
Thida Maung Myint, Chanel H. Y. Chong, Melanie Wyld, Brian Nankivell, Kathy Kable, Germaine Wong. Polyoma BK Virus in Kidney Transplant Recipients: Screening, Monitoring, and Management. Transplantation 2022; 106(1): e76 doi: 10.1097/TP.0000000000003801
|
11 |
Julien Gras, Arnaud Le Flécher, Axelle Dupont, Jérôme Vérine, Ali Amara, Constance Delaugerre, Jean Michel Molina, Marie Noëlle Peraldi. Characteristics, risk factors and outcome of BKV nephropathy in kidney transplant recipients: a case–control study. BMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08043-z
|
12 |
D. R. Prilepskaya, E. A. Domonova. A systematic review. Current understanding of the infection caused by <i>Betapolyomavirus hominis</i>. Journal Infectology 2023; 15(2): 24 doi: 10.22625/2072-6732-2023-15-2-24-34
|